Researchers at the Instituto de Investigación Sant Pau in Barcelona reviewed how specific depression symptoms relate to brain connectivity at rest. Their findings point to distinct brain-connectivity patterns. Anhedonia and rumination are linked to different patterns, as are insomnia and suicidal behaviour.
Depression may not be one brain disorder with one biological signature. The same formal diagnosis can cover very different clinical realities: patients may meet the criteria for major depressive disorder but differ sharply in their symptoms and their intensity.
The label is broad.
The study was published in Translational Psychiatry. Researchers examined existing evidence on functional connectivity at rest, focusing on clinical dimensions instead of treating depression as one uniform condition.
A separate report by Biermann Medizin on a broader study of major depression described 263 patients and 75 healthy participants. The analysis identified five brain-connectivity profiles associated with different clinical traits.
Earlier neurobiological reviews point in the same direction. Anhedonia has been linked to altered connectivity in reward-related systems, while rumination has been linked to activity or connectivity in the default mode network.
The current diagnostic system requires a minimum number of symptoms from internationally recognised manuals. Several combinations can lead to the same diagnosis. That flexibility helps clinicians identify depression, but it also creates wide differences among patients with the same label.
When researchers group patients with different symptom profiles together, consistent brain biomarkers become harder to find. Predicting who will respond to a particular treatment also becomes more difficult.
The British Journal of Psychiatry has reported that pronounced anhedonia is linked to suicidal thoughts and behaviour even after overall depression severity is taken into account. This adds to interest in symptom-based risk stratification, but does not make anhedonia a standalone diagnostic test.
The proposed alternative is dimensional. Doctors would begin with the symptom that defines a patient's clinical picture, then examine the brain circuits associated with it.
Anhedonia may involve a different connectivity pattern from rumination or insomnia. Suicidal behaviour may also show its own configuration. The review does not present a finished diagnostic test; it lays out evidence for a direction in future research and more precise clinical work.
This gap between a formal category and the conditions hidden inside it also appeared in an earlier report about how broad labels can obscure the details that shape what happens next.
A dimensional approach could help explain why two people with major depressive disorder follow different courses and respond differently to the same treatment.
The target would no longer be only the diagnostic label. It would include the patient's symptom pattern and the brain circuitry linked to it. That could give personalised psychiatry a clearer path.
Reviews of rumination add context to this model. They connect repetitive self-focused thinking with the default mode network, a system involved in internally oriented thought.
The study's basic contribution is straightforward: it does not treat diagnostic convenience as biological truth.
The evidence reviewed by IR Sant Pau supports a model in which depression includes partly distinct clinical dimensions rather than one homogeneous brain condition. Reports on Finnish brain-profile research describe the same wider effort to identify biologically meaningful subgroups.
The British Journal of Psychiatry has also highlighted the clinical relevance of anhedonia beyond overall depression severity. None of this replaces established diagnosis. It does support more specific assessment and treatment decisions tied to a patient's actual symptoms.
